COVID-19 and 2020 ACS Grants

We are aware of, and are monitoring, issues introduced by the COVID-19 pandemic that impact the American Cancer Society (ACS) grant application and administrative processes. See the updates below.

New print application deadline. We have extended the deadline for the printed application to May 15, 2020, 5 pm EDT to allow applicants more time to get the required administrative signatures and perhaps have access to other needed resources.

Announcement of COVID-19-related No-Cost Extension. Due to extenuating circumstances related to COVID-19, a streamlined, 6-month No-Cost Extension (NCE) is available for grant terms ending in 2020 for the following funding mechanisms:

  • Postdoctoral Fellowship (PF)
  • Research Scholar Grant (RSG)
  • Mentored Research Scholar Grant (MRSG)
  • Mission Boost Grant (MBG)
  • Pilot and Exploratory Projects in Palliative Care of Cancer Patients and their Families (PEP)
  • TheoryLab Collaborative Grant (TLC)
  • Graduate Scholarships in Cancer Nursing Practice (GSCNP)
  • Doctoral Degree Scholarships in Cancer Nursing (DSCN)
  • Master’s Training Grants in Clinical Oncology Social Work (MTGSW)
  • Doctoral Training Grants in Oncology Social Work (DTGSW)
  • Physician Training Awards in Cancer Prevention (PTACP)
  • Cancer Control Career Development Award (CCCDA) 

If you have one of the above mechanisms and would like to apply for a 6-month, no-cost extension, please go to proposalCENTRAL, and at the bottom of the deliverables tab, download and complete the COVID-19 Related No-Cost Extension Request Form.

After uploading the form, you will automatically receive an email confirming approval of the extended award term.

Note about standard NCE requests. The COVID-19-related NCE does not prevent request for a subsequent (up to 1-year) NCE, if allowable for that grant mechanism. 

COVID-19 effects on available grant funding. As with many businesses, it remains uncertain how the pandemic will affect the economy and donations to the American Cancer Society. This in turn may impact our ability to fund grants later in 2020 at the normal level, including those from the April 1 cycle. At this point, funding of grants at any level for the next cycle cannot be guaranteed. 

We remain committed to funding the most innovative cancer research and training in the country to benefit cancer patients and their families. To read more about what the American Cancer Society is doing to carry on our lifesaving mission, see the CEO message from Gary Reedy.